198 related articles for article (PubMed ID: 23578748)
1. PTEN plasticity: how the taming of a lethal gene can go too far.
Naguib A; Trotman LC
Trends Cell Biol; 2013 Aug; 23(8):374-9. PubMed ID: 23578748
[TBL] [Abstract][Full Text] [Related]
2. PTEN level in tumor suppression: how much is too little?
Carracedo A; Alimonti A; Pandolfi PP
Cancer Res; 2011 Feb; 71(3):629-33. PubMed ID: 21266353
[TBL] [Abstract][Full Text] [Related]
3. Non-genomic loss of PTEN function in cancer: not in my genes.
Leslie NR; Foti M
Trends Pharmacol Sci; 2011 Mar; 32(3):131-40. PubMed ID: 21236500
[TBL] [Abstract][Full Text] [Related]
4. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
Zhao D; Lu X; Wang G; Lan Z; Liao W; Li J; Liang X; Chen JR; Shah S; Shang X; Tang M; Deng P; Dey P; Chakravarti D; Chen P; Spring DJ; Navone NM; Troncoso P; Zhang J; Wang YA; DePinho RA
Nature; 2017 Feb; 542(7642):484-488. PubMed ID: 28166537
[TBL] [Abstract][Full Text] [Related]
5. The multiple layers of non-genetic regulation of PTEN tumour suppressor activity.
Correia NC; Gírio A; Antunes I; Martins LR; Barata JT
Eur J Cancer; 2014 Jan; 50(1):216-25. PubMed ID: 24054978
[TBL] [Abstract][Full Text] [Related]
6. Regulatory role of microRNAs on PTEN signaling.
Ghafouri-Fard S; Abak A; Shoorei H; Mohaqiq M; Majidpoor J; Sayad A; Taheri M
Biomed Pharmacother; 2021 Jan; 133():110986. PubMed ID: 33166764
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of PTEN loss in cancer: It's all about diversity.
Álvarez-Garcia V; Tawil Y; Wise HM; Leslie NR
Semin Cancer Biol; 2019 Dec; 59():66-79. PubMed ID: 30738865
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Hollander MC; Blumenthal GM; Dennis PA
Nat Rev Cancer; 2011 Apr; 11(4):289-301. PubMed ID: 21430697
[TBL] [Abstract][Full Text] [Related]
9. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
10. The functions and regulation of the PTEN tumour suppressor.
Song MS; Salmena L; Pandolfi PP
Nat Rev Mol Cell Biol; 2012 Apr; 13(5):283-96. PubMed ID: 22473468
[TBL] [Abstract][Full Text] [Related]
11. The functions and regulation of the PTEN tumour suppressor: new modes and prospects.
Lee YR; Chen M; Pandolfi PP
Nat Rev Mol Cell Biol; 2018 Sep; 19(9):547-562. PubMed ID: 29858604
[TBL] [Abstract][Full Text] [Related]
12. PTEN and the PI3-kinase pathway in cancer.
Chalhoub N; Baker SJ
Annu Rev Pathol; 2009; 4():127-50. PubMed ID: 18767981
[TBL] [Abstract][Full Text] [Related]
13. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
Cully M; You H; Levine AJ; Mak TW
Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
[TBL] [Abstract][Full Text] [Related]
14. PTEN: a promising pharmacological target to enhance epithelial wound healing.
Zhao M
Br J Pharmacol; 2007 Dec; 152(8):1141-4. PubMed ID: 17922021
[TBL] [Abstract][Full Text] [Related]
15. Tenets of PTEN tumor suppression.
Salmena L; Carracedo A; Pandolfi PP
Cell; 2008 May; 133(3):403-14. PubMed ID: 18455982
[TBL] [Abstract][Full Text] [Related]
16. Suppression of miR-21 Expression Inhibits Cell Proliferation and Migration of Liver Cancer Cells by Targeting Phosphatase and Tensin Homolog (PTEN).
Liu H; Cheng L; Cao D; Zhang H
Med Sci Monit; 2018 May; 24():3571-3577. PubMed ID: 29807978
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K
Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466
[TBL] [Abstract][Full Text] [Related]
19. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.
Chen ML; Xu PZ; Peng XD; Chen WS; Guzman G; Yang X; Di Cristofano A; Pandolfi PP; Hay N
Genes Dev; 2006 Jun; 20(12):1569-74. PubMed ID: 16778075
[TBL] [Abstract][Full Text] [Related]
20. Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN.
Zhao M; Song B; Pu J; Wada T; Reid B; Tai G; Wang F; Guo A; Walczysko P; Gu Y; Sasaki T; Suzuki A; Forrester JV; Bourne HR; Devreotes PN; McCaig CD; Penninger JM
Nature; 2006 Jul; 442(7101):457-60. PubMed ID: 16871217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
